Navigation Links
Advanced Life Sciences Announces Results of Shareholder Meeting and Provides Additional Information on Upcoming Advisory Committee Meeting
Date:4/2/2009

b>About Cethromycin

In November 2008, the FDA filed the Company's NDA for cethromycin and established a target Prescription Drug User Fee Act (PDUFA) action date for the cethromycin NDA of July 31, 2009. Cethromycin has shown higher in vitro potency and a broader range of activity than macrolides against Gram-positive bacteria, certain Gram-negative bacteria and atypical organisms associated with respiratory tract infections. In in vitro tests, it appears to be effective against penicillin- and macrolide-resistant bacteria. Cethromycin has a mechanism of action that may slow the onset of future bacterial resistance. In addition to its utility in CAP, cethromycin is also being investigated as a broad spectrum biodefense countermeasure to combat agents of bioterror including anthrax, tularemia, plague and melioidosis. The FDA has designated cethromycin as an orphan drug for the prophylactic treatment of inhalation anthrax post exposure, but the drug is not yet approved for this or any other indication.

About Advanced Life Sciences

Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer, respiratory diseases and biodefense. For more information, please visit us on the web at www.advancedlifesciences.com.

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to technology and product development,
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Survival differences by race most apparent in advanced stages of breast cancer
2. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
3. Advanced Age No Bar to Liver Transplant
4. Oncologists are critical in managing psychiatric disorders in patients with advanced cancer
5. Advanced technologies aim to transform the coaching of top athletes
6. Mecklenburg EMS Introduces Most-Advanced Situational Training in America for Emergency Medical Personnel
7. Advanced Life Sciences Joins NASDAQ Capital Market
8. Experimental drug shows promise in advanced kidney cancer
9. TCS Healthcare Technologies Announces Full Integration of Case Management Adherence Guidelines into Acuity Advanced Care(TM) System
10. OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research
11. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... Provo, Utah (PRWEB) , ... June 30, 2015 ... ... and corporate training, has released a new website intended for executives and administrators ... significantly enhance user experience, and the final product is a result of comprehensive ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... desire to educate readers and potential patients about a variety of plastic surgery ... cosmetic dentistry and more. , It has been the main focus of Cosmetic ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... to its multidisciplinary group of physicians and specialists. Dr. Cook is experienced with ... healthcare in hopes of achieving outstanding medical outcomes. , “We are very excited ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... Martin Del Campo is their newest FAA-certified medical examiner in the city of ... for all fledging pilots seeking to obtain their physical aviation certificates. Pilots hoping ...
(Date:6/29/2015)... Wisconsin (PRWEB) , ... June 29, 2015 , ... ... with the news that the European Medicines Agency (EMA) has granted accelerated approval ... “Melanoma remains a global public health threat and the approval of nivolumab for ...
Breaking Medicine News(10 mins):Health News:Career Step Launches New Website to Better Meet Needs of Partners, Clients and Others Searching for Corporate Training Solutions 2Health News:Board of Advisors Now Coming to Cosmetic Town 2Health News:Healthpointe in La Tijera Proudly Announces the Addition of a New Chiropractor 2Health News:Healthpointe in La Tijera Proudly Announces the Addition of a New Chiropractor 3Health News:Healthpointe Now Offering FAA Physical Exams in San Bernardino County 2Health News:Society for Immunotherapy of Cancer Reacts to EMA Approval of Nivolumab for Treatment of Metastatic Melanoma 2Health News:Society for Immunotherapy of Cancer Reacts to EMA Approval of Nivolumab for Treatment of Metastatic Melanoma 3
... overweight and obese people getting? More than many ... Case Western Reserve University,s Frances Payne Bolton School of ... Journal of the American Academy of Nurse Practitioners ... individuals." Deborah Walton Smith, who is now a ...
... failure who repress their emotions, especially anger, are more ... depression associated with knowledge about their disease, according to ... study influenced how depressed or anxious they felt. The ... more likely they were to have symptoms of depression ...
... Not a single person identified with autism or asperger,s ... they had the condition, research led by the University ... Professor of Psychiatry at the University of Leicester, the ... males, those without higher educational qualifications, and those living ...
... Children,s health problems caused by air pollution, exposure to toxic ... billion in 2008, a new study finds. That was ... compared with 2.8 percent in 1997, said researchers from the ... the cost of childhood cancer and chronic conditions such as ...
... studies have shown that a 64-detector CT angiography ... image but considerably reduced patient radiation dose when ... being presented at the 2011 American Roentgen Ray ... in the Department of Radiology at the University ...
... HealthDay Reporter , TUESDAY, May 3 (HealthDay News) -- The ... more than 12 percent between 2001 and 2009, U.S. health ... people, according to the U.S. Centers for Disease Control and ... million Americans have asthma "and that number, unfortunately, is rising," ...
Cached Medicine News:Health News:Making the move to exercise for overweight and obese people 2Health News:More knowledge not always helpful for women dealing with heart disease 2Health News:More knowledge not always helpful for women dealing with heart disease 3Health News:More knowledge not always helpful for women dealing with heart disease 4Health News:'Most adults with autism go undiagnosed' -- new findings 2Health News:'Most adults with autism go undiagnosed' -- new findings 3Health News:Treating Kids for Environmental Ills Costs U.S. $76B a Year 2Health News:Low-dose chest CT effective in reducing radiation for evaluation of cardiothoracic surgery patients 2Health News:Number of Americans With Asthma Keeps Rising 2Health News:Number of Americans With Asthma Keeps Rising 3
(Date:6/29/2015)... MELVILLE, N.Y. , June 29, 2015 /PRNewswire/ ... ), the world,s largest provider of health care ... and medical practitioners, announced today that it has ... by the Association of Hispanic Healthcare Executives (AHHE), ... and policies to increase the presence of Hispanic ...
(Date:6/29/2015)... 29, 2015  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... to the Russell 2000® Small Cap, Russell 3000®, and ... at the close of trading on June 26, 2015 ... of U.S. and global indexes. Sorrento is already a ... About the Russell Indexes. Russell indexes ...
(Date:6/29/2015)... SAN FRANCISCO , June 29, 2015 ... novel blood-draw technology has received CE Mark (Conformite ... from the European Union. This regulatory milestone further ... to one of the most common procedures in ... Velano Vascular,s proprietary device reduces the need ...
Breaking Medicine Technology:Henry Schein Selected As Corporation of the Year By The Association of Hispanic Healthcare Executives 2Henry Schein Selected As Corporation of the Year By The Association of Hispanic Healthcare Executives 3Henry Schein Selected As Corporation of the Year By The Association of Hispanic Healthcare Executives 4Henry Schein Selected As Corporation of the Year By The Association of Hispanic Healthcare Executives 5Henry Schein Selected As Corporation of the Year By The Association of Hispanic Healthcare Executives 6Sorrento Added to Russell 2000 Small Cap, Russell 3000 and Global Indexes 2Sorrento Added to Russell 2000 Small Cap, Russell 3000 and Global Indexes 3Velano Vascular Receives CE Mark For Novel Blood Draw Technology Designed to Reduce Needle Exposures for Hospitalized Patients and Healthcare Providers 2
... Inc. (the "Company") (Nasdaq: CMED ), a leading China-based ... the fourth fiscal quarter ("4Q FY2010") and the full fiscal year ... Highlight sFor   the   ...   31,   2010March   31, ...
... Medical, Inc. will sell its BioTREK technology platform, which has ... the firm Finn, Warnke & Gayton, LLP to be liquidated ... bid sale of June 10, 2011. BioTREK ... to create a family of percutaneous devices for repair or ...
Cached Medicine Technology:China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 2China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 3China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 4China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 5China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 6China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 7China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 8China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 9China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 10China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 11China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 12China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 13China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 14China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 15China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 16China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 17China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 18China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 19China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 20China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 21China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 22China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 23China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 24China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 25NMT Medical, Inc. to Sell BioTREK Technology Platform at Its Sealed Bid Sale on Friday, June 10, 2011 at Twelve O'Clock Noon 2
Dolwick-Reich Condyle periosteal elevator, 17.5 cm, 7"....
Molt periosteal elevator #9, 18.5 cm, 7-1/4"....
Obwegeser periosteal elevator, angled, 9 mm, 20 cm, 8"....
... Deformity System unites the clinical experience ... and Isola with revolutionary technology developed ... unsurpassed versatility, simplicity and security. Frontier ... versatility for treating a deformity from ...
Medicine Products: